GROUP PUBLICATIONS

Screenshot 2020-04-26 at 16.12.41.png

Ercolano et al, 2020

Nature Biotech.png

Racle et al, 2019

cover elife.png

Vanoni et al, 2021

JITC.jpg

Rockinger et al, 2020

Nature_Communications_-_Journal_Cover.jp

Ercolano et al, 2021

Sci Adv.gif

Cachot et al, 2021

2021

Scientific Articles

  • Ercolano G., Gomez-Cadena A., Dumauthioz N., Vanoni G., Kreutzfeldt M., Wyss T., Michalik L., Loyon R., Ianaro A., Ho P-C., Borg C., Kopf M., Merkler D., Krebs P., Romero P., Trabanelli S. and Jandus C. PPARg drives IL-33 dependent ILC2 pro-tumoral functions. Nat Comm 2021 May; 12(1):2538.

  • Saillard M., Cenerenti M., Romoro P. and Jandus C., Impact of Immunotherapy on CD4 T cell phenotypes and function in Cancer. Vaccines 2021

  • Hofmann M., Jandus C., Lee LN. and Utzschneider DT. Editorial: Memory T cells in chronic infections and tumors. Front Immunol 2021. 12:656010.

  • Cachot A, Bilous M, Liu Y-C, Li X, Saillard M, Cenerenti M, Rockinger AG, Wyss T, et al. Tumor-specific cytolytic CD4 T cells mediate immunity against human cancer. Sci Adv 2021; doi: 10.1126/sciadv.abe3348.

  • Vanoni G, Ercolano G, Candiani S, Rutigliani M, Lanata M, Derré L, Marcenaro E, Schneider P, et al. Human primed ILCPs support endothelial activation through NF-kB signaling. Elife 2021; doi: 10.7554/eLife.58838.

  • Gomez-Cadena A., Spehner L., Kroemer M., Ben Khelil M., Bouiller K., Verdeil G., Trabanelli S., Borg C., Loyon R. and Jandus C. Severe COVID-19 patients display an ILC2 NKG2D+ population in their impaired ILC compartment. Cell Mol Immunol 2021;18(2):484-486.

2020

Scientific Articles

Book Chapters

 

 

2019

Scientific Articles

 

 

2018

Scientific Articles

 

Professional Articles

 

 

2017

Scientific Articles

 

 

2016

Scientific Articles